1. Home
  2. CXW vs VERA Comparison

CXW vs VERA Comparison

Compare CXW & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CXW
  • VERA
  • Stock Information
  • Founded
  • CXW 1983
  • VERA 2016
  • Country
  • CXW United States
  • VERA United States
  • Employees
  • CXW N/A
  • VERA N/A
  • Industry
  • CXW Real Estate Investment Trusts
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CXW Real Estate
  • VERA Health Care
  • Exchange
  • CXW Nasdaq
  • VERA Nasdaq
  • Market Cap
  • CXW 2.5B
  • VERA 2.0B
  • IPO Year
  • CXW 1997
  • VERA 2021
  • Fundamental
  • Price
  • CXW $21.39
  • VERA $23.56
  • Analyst Decision
  • CXW Strong Buy
  • VERA Buy
  • Analyst Count
  • CXW 3
  • VERA 8
  • Target Price
  • CXW $32.67
  • VERA $64.63
  • AVG Volume (30 Days)
  • CXW 912.0K
  • VERA 1.2M
  • Earning Date
  • CXW 08-06-2025
  • VERA 08-07-2025
  • Dividend Yield
  • CXW N/A
  • VERA N/A
  • EPS Growth
  • CXW 36.58
  • VERA N/A
  • EPS
  • CXW 0.77
  • VERA N/A
  • Revenue
  • CXW $1,949,587,000.00
  • VERA N/A
  • Revenue This Year
  • CXW $5.37
  • VERA N/A
  • Revenue Next Year
  • CXW $14.18
  • VERA N/A
  • P/E Ratio
  • CXW $27.89
  • VERA N/A
  • Revenue Growth
  • CXW 0.53
  • VERA N/A
  • 52 Week Low
  • CXW $11.82
  • VERA $18.53
  • 52 Week High
  • CXW $24.99
  • VERA $51.61
  • Technical
  • Relative Strength Index (RSI)
  • CXW 48.45
  • VERA 51.58
  • Support Level
  • CXW $21.87
  • VERA $22.57
  • Resistance Level
  • CXW $22.30
  • VERA $24.58
  • Average True Range (ATR)
  • CXW 0.67
  • VERA 1.08
  • MACD
  • CXW 0.05
  • VERA 0.04
  • Stochastic Oscillator
  • CXW 41.94
  • VERA 42.38

About CXW CoreCivic Inc.

CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: